Minoru Ubukata

715 total citations
18 papers, 540 citations indexed

About

Minoru Ubukata is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Minoru Ubukata has authored 18 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 8 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Minoru Ubukata's work include Cyclopropane Reaction Mechanisms (6 papers), Catalytic C–H Functionalization Methods (4 papers) and Catalytic Alkyne Reactions (4 papers). Minoru Ubukata is often cited by papers focused on Cyclopropane Reaction Mechanisms (6 papers), Catalytic C–H Functionalization Methods (4 papers) and Catalytic Alkyne Reactions (4 papers). Minoru Ubukata collaborates with scholars based in Japan and United States. Minoru Ubukata's co-authors include Masahiro Murakami, Yoshihiko Ito, Kenichiro Itami, Takashi Inaba, Katsutaka Yasue, Masahiro Tanaka, Shinya Sato, Hideaki Ohgaki, Hiromasa Hasegawa and Toshiyuki Kato and has published in prestigious journals such as Angewandte Chemie International Edition, Environmental Health Perspectives and Journal of Medicinal Chemistry.

In The Last Decade

Minoru Ubukata

18 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minoru Ubukata Japan 12 397 93 65 51 23 18 540
Colin K. Skepper United States 13 371 0.9× 108 1.2× 36 0.6× 25 0.5× 5 0.2× 15 497
Ken‐ichi Tanji Japan 12 339 0.9× 160 1.7× 13 0.2× 31 0.6× 21 0.9× 53 466
Takeshi Kuribayashi Japan 11 177 0.4× 104 1.1× 32 0.5× 68 1.3× 21 0.9× 21 308
G. DESCOTES France 14 396 1.0× 236 2.5× 16 0.2× 69 1.4× 9 0.4× 64 543
Hsiencheng Shih United States 11 319 0.8× 145 1.6× 34 0.5× 17 0.3× 7 0.3× 17 500
Jean Defauw United States 13 270 0.7× 109 1.2× 37 0.6× 32 0.6× 4 0.2× 18 361
Deepkamal Karelia United States 11 233 0.6× 150 1.6× 23 0.4× 18 0.4× 4 0.2× 22 482
Gregory Yin Ming Cheng Hong Kong 8 242 0.6× 105 1.1× 27 0.4× 19 0.4× 2 0.1× 8 402
J. Somarajan Nair India 7 222 0.6× 124 1.3× 63 1.0× 10 0.2× 24 1.0× 16 372
Ramesh Deshidi India 11 330 0.8× 156 1.7× 18 0.3× 52 1.0× 7 0.3× 13 525

Countries citing papers authored by Minoru Ubukata

Since Specialization
Citations

This map shows the geographic impact of Minoru Ubukata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Ubukata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Ubukata more than expected).

Fields of papers citing papers by Minoru Ubukata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoru Ubukata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Ubukata. The network helps show where Minoru Ubukata may publish in the future.

Co-authorship network of co-authors of Minoru Ubukata

This figure shows the co-authorship network connecting the top 25 collaborators of Minoru Ubukata. A scholar is included among the top collaborators of Minoru Ubukata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoru Ubukata. Minoru Ubukata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hara, Yoshinori, Minoru Ubukata, Masafumi Inoue, et al.. (2024). Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein–Protein Interaction Inhibitors. Journal of Medicinal Chemistry. 67(5). 3741–3763. 3 indexed citations
2.
Ubukata, Minoru, Naoki Ogawa, Tsuyoshi Adachi, et al.. (2023). Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor. ACS Medicinal Chemistry Letters. 14(5). 658–665. 14 indexed citations
3.
Ito, Takashi, Shingo Fujioka, Minoru Ubukata, et al.. (2021). Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases. Bioorganic & Medicinal Chemistry. 44. 116283–116283. 11 indexed citations
4.
Hara, Yoshinori, Shingo Obika, Minoru Ubukata, et al.. (2021). Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitors. Bioorganic & Medicinal Chemistry. 52. 116514–116514. 3 indexed citations
5.
Watanabe, Takashi, et al.. (2019). Optimization of oxadiazole derivatives with a spirocyclic cyclohexane structure as novel GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 29(16). 2100–2106. 6 indexed citations
6.
Iida, Tetsuya, Minoru Ubukata, Yuichi Nakagawa, et al.. (2018). Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity. European Journal of Medicinal Chemistry. 158. 832–852. 25 indexed citations
7.
Watanabe, Takashi, et al.. (2018). Lead generation and optimization of novel GPR119 agonists with a spirocyclic cyclohexane structure. Bioorganic & Medicinal Chemistry Letters. 29(3). 373–379. 6 indexed citations
8.
Tanaka, Masahiro, et al.. (2007). One-Step Synthesis of Heteroaromatic-Fused Pyrrolidines via Cyclopropane Ring-Opening Reaction:  Application to the PKCβ Inhibitor JTT-010. Organic Letters. 9(17). 3331–3334. 81 indexed citations
9.
10.
Tanaka, Masahiro, Shoichi Sagawa, Katsutaka Yasue, et al.. (2006). Synthesis, SAR studies, and pharmacological evaluation of 3-anilino-4-(3-indolyl) maleimides with conformationally restricted structure as orally bioavailable PKCβ-selective inhibitors. Bioorganic & Medicinal Chemistry. 14(17). 5781–5794. 39 indexed citations
11.
Murakami, Masahiro, Minoru Ubukata, & Yoshihiko Ito. (2002). Ruthenium-Mediated Domino Sequence Forming Six-Membered Ring Diene from Ene-Yne and Alkene. Chemistry Letters. 31(3). 294–295. 19 indexed citations
12.
Murakami, Masahiro, Minoru Ubukata, Kenichiro Itami, & Yoshihiko Ito. (1998). Rhodium-Catalyzed Intermolecular [4+2] Cycloaddition of Unactivated Substrates. Angewandte Chemie International Edition. 37(16). 2248–2250. 72 indexed citations
13.
Murakami, Masahiro, et al.. (1998). New Cycloaddition Reactions of Conjugated Allenes Catalyzed by Transition Metal Complexes.. Journal of Synthetic Organic Chemistry Japan. 56(5). 406–412. 2 indexed citations
14.
Murakami, Masahiro, et al.. (1998). Iridium-Catalyzed [5 + 1] Cycloaddition:  Allenylcyclopropane as a Five-Carbon Assembling Unit. The Journal of Organic Chemistry. 63(1). 4–5. 87 indexed citations
15.
Tomita, Ikuyoshi, Minoru Ubukata, & Takeshi Endo. (1998). Synthesis of novel reactive polymers bearing naphthalene moieties in the side chain by the living coordination polymerization of allene derivatives. Reactive and Functional Polymers. 37(1-3). 27–32. 11 indexed citations
16.
Murakami, Masahiro, Minoru Ubukata, & Yoshihiko Ito. (1998). Ruthenium-catalyzed coupling of unactivated olefins with unactivated alkynes. Tetrahedron Letters. 39(40). 7361–7364. 51 indexed citations
17.
Murakami, Masahiro, Minoru Ubukata, Kenichiro Itami, & Yoshihiko Ito. (1998). Rhodium-vermittelte, intermolekulare [4+2]-Cycloadditionen von nichtaktivierten Substraten. Angewandte Chemie. 110(16). 2362–2364. 23 indexed citations
18.
Ohgaki, Hideaki, Hiromasa Hasegawa, Toshiyuki Kato, et al.. (1986). Carcinogenicity in mice and rats of heterocyclic amines in cooked foods.. Environmental Health Perspectives. 67. 129–134. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colin K. Skepper Breakdown of academic impact, for papers by Ken‐ichi Tanji Breakdown of academic impact, for papers by Takeshi Kuribayashi Breakdown of academic impact, for papers by G. DESCOTES Breakdown of academic impact, for papers by Hsiencheng Shih Breakdown of academic impact, for papers by Jean Defauw Breakdown of academic impact, for papers by Deepkamal Karelia Breakdown of academic impact, for papers by Gregory Yin Ming Cheng Breakdown of academic impact, for papers by J. Somarajan Nair Breakdown of academic impact, for papers by Ramesh Deshidi
Rankless by CCL
2026